Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06847282 · ClinicalTrials.gov registry record

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

A clinical trial of Muscular Dystrophy, Facioscapulohumeral, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
80
Enrollment target
7
Study locations

NCT06847282 is a study of Muscular Dystrophy, Facioscapulohumeral that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 80 participants. The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06847282, a study of Muscular Dystrophy, Facioscapulohumeral, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
80 participants
Enrollment target
7
Study locations

Study Summary

The primary goal of this study is to validate motor and functional outcomes and refine clinical trial strategies for pediatric-onset FSHD

Study Locations (7)

California

  • Stanford University - Palo Alto

Iowa

  • University of Iowa - Iowa City

Kansas

  • University of Kansas Medical Center - Kansas City

New York

  • University of Rochester - Rochester

North Carolina

  • Duke University - Durham

Utah

  • University of Utah - Salt Lake City

Other

  • Murdoch Children's Research Institute - Melbourne

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-05-22
Est. Completion 2028-05

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT06847282

The ClinicalTrials.gov registry entry for NCT06847282 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Muscular Dystrophy, Facioscapulohumeral appearing as the primary indexed condition, and to 0 interventions.

NCT06847282 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Iowa, Kansas.

Frequently Asked Questions

What is clinical trial NCT06847282 about?

NCT06847282 is a clinical study titled "Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)". The primary goal of this study is to validate motor and functional outcomes and refine clinical trial strategies for pediatric-onset FSHD

What is the current status of trial NCT06847282?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-05-22. Estimated completion is 2028-05.

What conditions does trial NCT06847282 study?

This clinical trial studies the following conditions: Muscular Dystrophy, Facioscapulohumeral.

Who is sponsoring clinical trial NCT06847282?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06847282 being conducted?

This trial has 7 study locations across California, Iowa, Kansas, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscular Dystrophy, Facioscapulohumeral

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.